Dear Researchers,

The library will operate on a duty schedule between 22 December 2025 and 4 January 2026. During this period, it will be possible to upload publications, but all other services will be suspended.

Thank you for your understanding.

Sári Zsuzsanna Réka

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

1998-2015

2015

Hegedűs, C., Kovács, D. K., Kiss, R., Sári, R., Németh, J., Szilvássy, Z., Peitl, B.: Effect of long-term olanzapine treatment on meal-induced insulin sensitization and on gastrointestinal peptides in female Sprague-Dawley rats.
J. Psychopharmacol. 29 (12), 1271-1279, 2015.

doi DEA WoS Scopus

Journal metrics:

D1 Medicine (miscellaneous)

Q1 Pharmacology

D1 Pharmacology (medical)

Q1 Psychiatry and Mental Health

Kovács, D. K., Hegedűs, C., Kiss, R., Sári, R., Németh, J., Szilvássy, Z., Peitl, B.: Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats.
Naunyn-Schmiedebergs Arch. Pharmacol. 388 (5), 525-530, 2015.

doi DEA

Journal metrics:

Q2 Medicine (miscellaneous)

Q2 Pharmacology

2013

Lelesz, B., Tóth, G. K., Peitl, B., Hegedűs, C., Drimba, L., Sári, R., Szilvássy, Z., Németh, J.: Description and application of a novel glucagon-like peptide-1 (GLP-1) radioimmunoassay.
J. Radioanal. Nucl. Chem. 299, 157-164, 2013.

doi DEA

Journal metrics:

Q2 Analytical Chemistry

Q3 Health, Toxicology and Mutagenesis

Q2 Nuclear Energy and Engineering

Q2 Pollution

Q2 Public Health, Environmental and Occupational Health

Q2 Radiology, Nuclear Medicine and Imaging

Q3 Spectroscopy

Kovács, D. K., Simon, Z., Hári, P., Málnási-Csizmadia, A., Hegedűs, C., Drimba, L., Németh, J., Sári, R., Szilvássy, Z., Peitl, B.: Identification of PPARγ ligands with One-dimensional Drug Profile Matching.
Drug Des. Devel. Ther. 7, 917-928, 2013.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q1 Pharmaceutical Science

Q2 Pharmacology

Hegedűs, C., Kovács, D. K., Drimba, L., Sári, R., Varga, A., Németh, J., Szilvássy, Z., Peitl, B.: Investigation of the metabolic effects of chronic clozapine treatment on CCK-1 receptor deficient Otsuka Long Evans Tokushima Fatty (OLETF) rats.
Eur. J. Pharmacol. 718 (1-3), 188-196, 2013.

doi DEA

Journal metrics:

Q2 Pharmacology

Drimba, L., Németh, J., Sári, R., Di, Y., Kovács, A., Szénási, G., Szilvássy, Z., Peitl, B.: In Vivo Preclinical Evaluation of a Promising Antiarrhythmic Agent, EGIS-7229.
Drug. Dev. Res. 74 (3), 173-185, 2013.

doi DEA

Journal metrics:

Q3 Drug Discovery

Drimba, L., Döbrönte, R., Hegedűs, C., Sári, R., Di, Y., Németh, J., Szilvássy, Z., Peitl, B.: The role of acute hyperinsulinemia in the development of cardiac arrhythmias.
Naunyn Schmiedebergs Arch. Pharmacol. 386 (5), 435-444, 2013.

doi DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q2 Pharmacology

2012

Drimba, L., Hegedűs, C., Yin, D., Sári, R., Németh, J., Szilvássy, Z., Peitl, B.: Beneficial Cardiac Effects of Cicletanine in Conscious Rabbits With Metabolic Syndrome.
J. Cardiovasc. Pharmacol. 60 (2), 208-218, 2012.

doi DEA

Journal metrics:

Q1 Cardiology and Cardiovascular Medicine

Q1 Pharmacology

Szilvássy, Z., Németh, J., Kovács, P., Paragh, G., Sári, R., Vígh, L., Peitl, B.: Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
Metabolism. 61 (6), 776-786, 2012.

doi DEA

Journal metrics:

Q2 Endocrinology

Q1 Endocrinology, Diabetes and Metabolism

10.

Fürjes, G., Tóth, G. K., Peitl, B., Pórszász, R., Lelesz, B., Sári, R., Tóth, A., Szilvássy, Z., Németh, J.: Thrittene radioimmunoassay: description and application of a novel method.
J. Radioanal. Nucl. Chem. 292 (1), 113-118, 2012.

doi DEA

Journal metrics:

Q2 Analytical Chemistry

Q3 Health, Toxicology and Mutagenesis

Q2 Nuclear Energy and Engineering

Q2 Pollution

Q2 Public Health, Environmental and Occupational Health

Q2 Radiology, Nuclear Medicine and Imaging

Q3 Spectroscopy

2010

11.

Peitl, B., Döbrönte, R., Drimba, L., Sári, R., Varga, A., Németh, J., Pázmány, T., Szilvássy, Z.: Involvement of cholecystokinin in baseline and post-prandial whole body insulin sensitivity in rats.
Eur. J. Pharmacol. 644 (1-3), 251-256, 2010.

doi DEA

Journal metrics:

Q2 Pharmacology

2009

12.

Peitl, B., Döbrönte, R., Németh, J., Pankucsi, C., Sári, R., Varga, A., Szilvássy, Z.: Meal-induced enhancement in insulin sensitivity is not triggered by hyperinsulinemia in rats.
Metab. Clin. Exp. 58 (3), 328-332, 2009.

doi DEA

Journal metrics:

Q2 Endocrinology

Q1 Endocrinology, Diabetes and Metabolism

13.

Peitl, B., Döbrönte, R., Drimba, L., Sári, R., Németh, J., Szilvássy, Z.: Role of sensory neurons on pancreatic beta cell function and on development of insulin resistance.
BMC Pharmacol. 9 (Suppl), A54, 2009.

doi DEA

2007

14.

Szilvássy, Z., Szaszkó, J., Döbrönte, R., Németh, J., Sári, R., Pankucsi, C., Varga, A., Tőzsér, J., Fésüs, L., Peitl, B.: Nitrate tolerance-induced deterioration of the ischemic adaptability of the heart.
BMC Pharmacol. 7 (Suppl.), A49, 2007.

doi DEA

15.

Peitl, B., Drimba, L., Döbrönte, R., Németh, J., Sári, R., Pankucsi, C., Varga, A., Fésüs, L., Tőzsér, J., Szilvássy, Z.: The possible link between insulin resistance and increased cardiovascular mortality.
BMC Pharmacol. 7 (Suppl.), A48, 2007.

doi DEA

2006

16.

Szilvássy, J., Sziklai, I., Sári, R., Németh, J., Peitl, B., Pórszász, R., Lonovics, J., Szilvássy, Z.: Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy.
Eur. J. Pharmacol. 531 (1-3), 217-225, 2006.

doi DEA

Journal metrics:

Q1 Pharmacology

2005

17.

Pálvölgyi, A., Sári, R., Németh, J., Szabolcs, A., Nagy, I., Hegyi, P. J., Lonovics, J., Szilvássy, Z.: Interplay between nitric oxide and VIP in CCK-8-induced phasic contractile activity in the rabbit sphincter of Oddi.
World J. Gastroenterol. 11 (21), 3264-3266, 2005.

DEA

Journal metrics:

Q2 Gastroenterology

Q2 Medicine (miscellaneous)

2004

18.

Sári, R., Peitl, B., Kovács, P., Lonovics, J., Pálvölgyi, A., Hegyi, P. J., Nagy, I., Németh, J., Szilvássy, Z., Pórszász, R.: Cyclic GMP-mediated activation of a glibenclamide-sensitive mechanism in the rabbit sphincter of Oddi.
Dig. Dis. Sci. 49 (3), 514-520, 2004.

doi DEA

Journal metrics:

Q1 Gastroenterology

Q3 Physiology

19.

Sári, R., Pálvölgyi, A., Rakonczay, Z., Takács, T., Lonovics, J., Czakó, L., Szilvássy, Z., Hegyi, P. J.: Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro.
World J. Gastroenterol. 10 (23), 3470-3474, 2004.

DEA

Journal metrics:

Q2 Gastroenterology

Q2 Medicine (miscellaneous)

2001

20.

Sári, R., Németh, J., Pórszász, R., Horváth, P., Blasig, I. E., Ferdinándy, P., Nagy, I., Lonovics, J., Szilvássy, Z.: Impairment by lovastatin of neural relaxation of the rabbit sphincter of Oddi.
Eur. J. Pharmacol.. 432 (1), 91-97, 2001.

doi DEA

Journal metrics:

Q1 Pharmacology

2000

21.

Németh, J., Thán, M., Oroszi, G., Sári, R., Szolcsányi, J., Szilvássy, Z.: Decreased sensory neuropeptide release from trachea of rats with streptozotocin-induced diabetes.
Eur. J. Pharmacol. 369 (2), 221-224, 2000.

doi DEA

Journal metrics:

Q1 Pharmacology

1999

22.

Németh, J., Thán, M., Sári, R., Peitl, B., Oroszi, G., Farkas, B., Szolcsányi, J., Szilvássy, Z.: Impairment of neurogenic inflammatory and anti-inflammatory responses in diabetic rats.
Eur. J. Pharmacol. 386 (1), 83-88, 1999.

doi DEA

Journal metrics:

Q1 Pharmacology

1998

23.

Sári, R., Jakab, I., Nagy, I., Lonovics, J., Szilvássy, Z.: Cross tolerance between nitroglycerin and neural relaxation of the rabbit sphincter of Oddi.
Pharmacol. Res. 37 (6), 505-512, 1998.

doi DEA

24.

Szilvássy, Z., Sári, R., Németh, J., Nagy, I., Csáti, S., Lonovics, J.: Improvement of nitrergic relaxation by farnesol of the sphincter of Oddi from hypercholesterolaemic rabbits.
Eur. J. Pharmacol. 353 (1), 75-78, 1998.

doi DEA